Pomegranate as an Anti-Prostate Cancer Food
Posted on 2009-10-30 06:00:00 in
Men's Health |
More than half a million men worldwide are diagnosed with prostate cancer every year, with over 200,000 deaths resulting from the disease. In that the cytochrome P450 enzyme, CYP1B1, is an established target in prostate cancer chemoprevention, scientists are engaged in efforts to identify compounds that inhibit CYP1B1 activity and thus confer beneficial effects against prostate cancer development. Daneel Ferreira, from the University of Mississippi (USA), and colleagues performed an in vitro experiment that found that two antioxidants present in pomegranates, the ellagitannin compounds of punicalagins and punicalins, exert potent capacities to inhibit CYP1B1.
Continue reading…
Sashi G. Kasimsetty, Dobroslawa Bialonska, Muntha K. Reddy, Cammi Thornton, Kristine L. Willett, Daneel Ferreira. “Effects of Pomegranate Chemical Constituents/Intestinal Microbial Metabolites on CYP1B1 in 22Rv1 Prostate Cancer Cells.” J. Agric. Food Chem., October 26, 2009; DOI: 10.1021/jf902716r.
Health Headlines MORE »
For every 10 g per day increase in soluble fiber intake, a woman may reduce her risk of breast cancer by up to 26%.
Peptides from soybeans modulate neurotransmitters, thereby helping to boost circulation in the brain.
Capsaicin (found in hot peppers) and capsiates (present in sweet peppers) exert modest weight management benefits.
While over 20% of U.S. adults receive periodic health examinations each year, many do not receive recommended preventive screening tests and counseling services
Researchers from Norway suggest a mechanism by which stress may make a person fat, and being obese may create stress.
Swedish researchers report that people who are short on sleep experience greater levels of hunger.
Among women with Generalized Anxiety Disorder (GAD), regular physical activity helps to reduce anxiety, irritability, feelings of tension, low energy and pain.
For every 100 mg per-day increase in magnesium in the diet, stroke risk may decline by up to 9%.
The best male marathon runners over age 65, and the best female marathon runners over age 45, continue to consistently improve their performance.
UCLA-led team safely uses human embryonic stem cells to treat macular degeneration.
